Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

This CTD dossier owner and manufacturer is a quality-driven, customer-centric pharmaceutical manufacturer specializing in generic finished dosage formulations. A subsidiary of a multinational group headquartered in Southeast Asia, it boasts an annual turnover exceeding US$150 million and operates as both a contract manufacturer for global MNCs and a producer of its own branded medications. The company emphasizes affordability and accessibility, aiming to meet unmet patient needs. Their focus lies on developing products across multiple therapy areas, utilizing various dosage forms. They possess GMP certifications and hold patents for their products. While primarily based in South Asia, they aim to expand their reach into the EU and North America through strategic partnerships and collaborations.